Ningbo MedicalSystem Biotechnology Co Ltd Cash Flow Reinvestment Rate
Ningbo MedicalSystem Biotechnology Co Ltd cash flow reinvestment rate. Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a Cash Flow Reinvestment Rate of 0.24x as of September 2025, reinvesting CN¥11.70 Million (capex CN¥11.70 Million ) from operating cash flow of CN¥48.96 Million. Explore Ningbo MedicalSystem Biotechnology Co Lt (300439) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)
Cash flow reinvestment rate of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. Historical reinvestment intensity for Ningbo MedicalSystem Biotechnology Co Ltd across 13 annual periods. Explore 300439 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Ningbo MedicalSystem Biotechnology Co Ltd Cash Flow Reinvestment Rate by Year (2011–2024)
Ningbo MedicalSystem Biotechnology Co Ltd cash flow reinvestment rate by year from 2011 to 2024. Year-by-year capital reinvestment analysis for Ningbo MedicalSystem Biotechnology Co Ltd. For the full cash flow conversion analysis, see Ningbo MedicalSystem Biotechnology Co Lt cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.51x | CN¥600.34 Million | CN¥397.81 Million | CN¥420.54 Million | ▲ +190.8% |
| 2023 | 0.52x | CN¥328.73 Million | CN¥633.53 Million | CN¥280.37 Million | ▼ -9.2% |
| 2022 | 0.57x | CN¥322.73 Million | CN¥564.67 Million | CN¥303.13 Million | ▲ +18.2% |
| 2021 | 0.48x | CN¥249.16 Million | CN¥515.48 Million | CN¥201.82 Million | ▲ +12.3% |
| 2020 | 0.43x | CN¥392.67 Million | CN¥912.07 Million | CN¥383.43 Million | ▼ -29.4% |
| 2019 | 0.61x | CN¥366.80 Million | CN¥601.17 Million | CN¥363.20 Million | ▼ -58.1% |
| 2018 | 1.46x | CN¥610.55 Million | CN¥418.80 Million | CN¥446.22 Million | ▼ -99.4% |
| 2016 | 249.71x | CN¥612.72 Million | CN¥2.45 Million | CN¥292.59 Million | ▲ +11584.0% |
| 2015 | 2.14x | CN¥379.46 Million | CN¥177.55 Million | CN¥92.27 Million | ▲ +238.2% |
| 2014 | 0.63x | CN¥73.63 Million | CN¥116.51 Million | CN¥73.63 Million | ▼ -12.9% |
| 2013 | 0.73x | CN¥72.61 Million | CN¥100.06 Million | CN¥72.61 Million | ▼ -40.0% |
| 2012 | 1.21x | CN¥56.60 Million | CN¥46.78 Million | CN¥56.60 Million | ▲ +96.3% |
| 2011 | 0.62x | CN¥30.71 Million | CN¥49.82 Million | CN¥30.71 Million | — |